Biomup

Hemostasis Made Simple

Home Team GEORGE MAKHOUL

GEORGE MAKHOUL

CEO of Biom’up USA, Inc

Mr. Makhoul has a track record in commercializing medical products to hospitals and surgeons combined with a strong experience of the US hemostasis market.
George Makhoul has over 16 years of sales, marketing, and business development leadership experience in both the medical device and pharmaceutical industries, specifically in hemostasis as well as over 13 years of targeted focus in Biosurgery, Orthopedics, and Biologics. He has led teams on both a large and small scale ranging from $10M – $1.8B in annual revenues.
Prior to joining Biom’Up, Mr. Makhoul spent eight years at Stryker in multiple senior leadership positions. While at Stryker, Mr. Makhoul successfully led the sales and marketing functions of two separate new divisions within Stryker’s Orthobiologics business unit, including leading teams that developed products from conception to commercialization. Other organizations he has served prior to Stryker are Wyeth (now Pfizer), Genzyme, and Precision Therapeutics.
George Makhoul holds a degree in Business Management from Moravian College.

Our final goal is without compromise:

The development of our biomaterials to improve patients' Quality of Life is paramount.